Results 131 to 140 of about 5,822 (192)

The Value of MRI and Radiomics for the Diagnostic Evaluation of Thyroid-Associated Ophthalmopathy. [PDF]

Diagnostics (Basel)
Zhou W, Song Y, Shi J, Li T.
europepmc   +1 more source

Retinal and Choroidal Alterations in Thyroid-Associated Ophthalmopathy: A Systematic Review. [PDF]

Life (Basel)
Ioana AM, Andrei D, Iacob D, Bolintineanu SL.   +3 more
europepmc   +1 more source

Targeted Delivery of CD34 Aptamer-Coupled Tocilizumab Microspheres for Effective Treatment of Thyroid-Associated Ophthalmopathy. [PDF]

Invest Ophthalmol Vis Sci
Luo Y, Yin J, Cao J, Xie B, Zhang F, Ouyang S, Zhou J, Tan Y, Xiong W.   +8 more
europepmc   +1 more source

Application of protein A immunoadsorption in thyroid-associated ophthalmopathy (TAO): study protocol for a non-randomised controlled clinical trial. [PDF]

BMJ Open
Lu S, Chen H, Liu S, Zhang F, Xiong W.
europepmc   +1 more source

Machine learning unveils hypoxia-immune gene hub for clinical stratification of thyroid-associated ophthalmopathy. [PDF]

Sci Rep
Chen L, Wang S, Wang J, Xu B, Tan J, Xia X.   +5 more
europepmc   +1 more source

Percutaneous para-levator palpebrae superioris and subconjunctival injection of triamcinolone acetonide for upper eyelid retraction in thyroid-associated ophthalmopathy. [PDF]

Front Med (Lausanne)
Wang M, Luan Y, Qian Z, Wang Y, Fang W.
europepmc   +1 more source

LSD1 induces H3 K9 demethylation to promote adipogenesis in thyroid-associated ophthalmopathy. [PDF]

Epigenetics Chromatin
Xu Y, Hu J, Fan Y, Sun L, Shen N, Jin Q, Zhang L, Zhang J, Zhang F, Chen H.   +9 more
europepmc   +1 more source

Exploring new horizons in CAR-based therapy for the treatment of thyroid-associated ophthalmopathy. [PDF]

Mil Med Res
Zhu XY, Zhou WY, Li T.
europepmc   +1 more source

Orbital computed tomography imaging characteristics of thyroid-associated ophthalmopathy. [PDF]

Sci Rep
Xiong C, Ren Z, Li X, Jin Q, Wang S, Gan P, Wang Y, Liao H.   +7 more
europepmc   +1 more source

Triamcinolone acetonide and botulinum toxin A for upper eyelid retraction in thyroid-associated ophthalmopathy. [PDF]

Sci Rep
Huang Z, Xu M, Zhang W, Song X.
europepmc   +1 more source